Prognostic Significance of the European LeukemiaNet Standardized System for Reporting Cytogenetic and Molecular Alterations in Adults With Acute Myeloid LeukemiaKrzysztof Mrózek, Clara D. Bloomfield, Guido Marcucci et al.|Journal of Clinical Oncology|2012Cited by 408
ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic categoryKlaus H. Metzeler, Clara D. Bloomfield, Heiko Becker et al.|Blood|2011Cited by 278
<i>RUNX1</i> Mutations Are Associated With Poor Outcome in Younger and Older Patients With Cytogenetically Normal Acute Myeloid Leukemia and With Distinct Gene and MicroRNA Expression SignaturesJason H. Mendler, Clara D. Bloomfield, Kati Maharry et al.|Journal of Clinical Oncology|2012Cited by 268
Age-Related Prognostic Impact of Different Types of <i>DNMT3A</i> Mutations in Adults With Primary Cytogenetically Normal Acute Myeloid LeukemiaGuido Marcucci, Clara D. Bloomfield, Klaus H. Metzeler et al.|Journal of Clinical Oncology|2012Cited by 255
Expression and prognostic impact of lncRNAs in acute myeloid leukemiaRamiro Garzon, Clara D. Bloomfield, Stefano Volinia et al.|Proceedings of the National Academy of Sciences|2014Cited by 233